Skip to
  1. Homepage
  2. Rare diseases
  3. Search
Simple search

Simple search

*
(*) mandatory field





 

Other search option(s)

Buschke-Ollendorff syndrome

Orpha number ORPHA1306
Synonym(s) Disseminated dermatofibrosis with osteopoikilosis
Prevalence -
Inheritance Autosomal dominant
Age of onset All ages
ICD-10
  • Q78.8
ICD-O -
OMIM
UMLS -
MeSH
  • C537415
MedDRA -
SNOMED CT -

Summary

Buschke-Ollendorff syndrome (BOS) is a benign disorder characterized by the association of osteopoikilosis lesions (``spotted bones'') in the skeleton and connective tissue nevi in the skin. The exact prevalence is unknown but BOS is believed to affect around 1 in 20,000 individuals. Onset may occur at any age and expression of the bone and skin lesions is variable. Osteopoikilosis is characterized by small and round spots of increased bone density that are mainly located in the epiphyseal regions of the tubular bones. They are harmless and usually found by chance when radiographs are taken for other purposes, although pain and limited joint mobility have been reported in a minority of patients. The number of lesions can vary from a few to many lesions, usually found in the shoulders, elbows, wrists, pelvis, knees and ankles. The skin lesions encountered in the BOS are connective tissue nevi. These lesions can present as either widely disseminated, skin-colored to yellow small papules or as more localized larger lesions referred to as yellow plaques. In families with BOS, affected individuals can have both bone and skin lesions, or just one of these manifestations. Melorheostosis (see this term) has been described in some patients from BOS families. BOS is inherited in an autosomal dominant manner and is caused by heterozygous loss-of-function mutations in the LEMD3 gene (12q14). This gene codes for the inner nuclear membrane protein, LEMD3, which interacts with both the BMP and TGF-beta signaling pathways. Diagnosis of BOS is made by histological analysis of skin lesions and radiographic bone evaluation. Histologically, the skin lesions show a variable degree of connective tissue anomalies, mainly affecting the collagen and elastic fibers. The collagen bundles can be thickened and broad and the elastic fibers increased, irregular or fragmented but not calcified as is seen in pseudoxanthoma elasticum (see this term). The bone lesions can be scarce at a youngage and therefore be missed early in life. Ultrastructural examination of the bone lesions shows that they represent foci of numerous bone trabeculae that are slightly thicker than normal. These bone lesions should be differentiated from melorheostosis and sclerotic bone metastases. Osteopoikilosis also occurs as an isolated finding in individuals without a family history of BOS, as well as in association with other sclerosing dysplasias and as part of the 12q14 microdeletion syndrome (see these terms). As both the bone and skin lesions in BOS are generally asymptomatic, correct diagnosis is important to avoid unnecessary examinations and treatment. The prognosis for patients is good.

Expert reviewer(s)

  • Pr Geert MORTIER

(*) Required fields.

Attention: Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. For all other comments, please send your remarks via contact us. Only comments written in English can be processed.


Captcha image

Detailed information

Summary information
Review article
  • EN (2009)
Get Acrobat Reader
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.